NATCO PHARMA
Natco Pharma is a manufacture and market affordable medicines that comply with global standards and to achieve market leadership in domestic as well as international markets.
NATCO PHARMA
Industry:
Health Care Manufacturing Medical
Founded:
1995-01-01
Status:
Active
Contact:
+91-40-2354 7532
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
ConvaTec
ConvaTec specializes in the development, manufacture, distribution of single-use devices to hospitals and healthcare sectors.
DJO Global
DJO Global is a manufacturer and distributor of medical devices for musculoskeletal health, vascular health, and pain management.
Letaotao
Letaotao is a manufacturer of herbal medicine and health care products.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-01-02 | Dash Pharmaceuticals | Dash Pharmaceuticals acquired by Natco Pharma | 18 M USD |
Investors List
CX Partners
CX Partners investment in Post-IPO Equity - Natco Pharma
Multiples
Multiples investment in Post-IPO Equity - Natco Pharma
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-08 | Eyestem | Natco Pharma investment in Series A - Eyestem | 510 M INR |
| 2021-03-24 | Cancer Clinics | Natco Pharma investment in Venture Round - Cancer Clinics | 1.5 M USD |
| 2019-12-28 | Cancer Clinics | Natco Pharma investment in Series A - Cancer Clinics | 140 K USD |
| 2017-11-04 | PACE Hospitals | Natco Pharma investment in Seed Round - PACE Hospitals | 75 M INR |
More informations about "Natco Pharma"
Natco Pharma - Wikipedia
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. See details»
Org Chart Natco Pharma - The Official Board
The org chart of Natco Pharma contains its 37 main executives including Rajeev Nannapaneni, S.V.V.N Appa Rao and Sandeep Kumar.See details»
Natco Pharma (Canada) Inc. | Canada's High Quality …
NATCO PHARMA (CANADA) INC. 2000 Argentia Road, Plaza 1, Suite 200 Mississauga, Ontario L5N 1P7 Tel: (905) 997-3353 / (905) 593-1566 Fax: (905) 997-3354See details»
Natco Pharma
At Natco we manufacture niche and complex Pharma products under the pressure of expectation. The need of society creates a global demand for affordable drugs, which we are focused on …See details»
NATCO Pharma Company Profile | Management and Employees …
NATCO Pharma Profile and History. Natco Pharma (Canada) Inc. (NATCO CANADA) is a Canadian subsidiary of Natco Pharma Limited, India. Natco Pharma Limited (NATCO) is a …See details»
Natco Pharma Ltd Company Profile - GlobalData
Natco Pharma Ltd (Natco Pharma) is a vertically integrated pharmaceutical company. It focuses on the development, manufacturing, and marketing of finished dosage formulations (FDF) and …See details»
Natco Pharma (Canada) Inc. - LinkedIn
Natco Pharma (Canada) Inc. is the Canadian subsidiary of Natco Pharma Limited. We are a vertically integrated pharmaceutical company focused on R&D and the manufacturing of drug products.See details»
Operations - Natco Pharma (Canada) Inc.
At NATCO, we pride ourselves on high-quality manufacturing from our world-class manufacturing facilities. ... NATCO PHARMA (CANADA) INC. 2000 Argentia Road, Plaza 1, Suite 200 Mississauga, Ontario L5N 1P7 Tel: (905) …See details»
Natco Pharma - Crunchbase Investor Profile
Natco Pharma is a manufacture and market affordable medicines that comply with global standards and to achieve market leadership in domestic as well as international markets. Lists Featuring This Company. Edit Lists Featuring This …See details»
NATCO - Crunchbase Company Profile & Funding
Legal Name Natco Pharma (Canada) Inc. Company Type For Profit; Contact Email [email protected]; Phone Number +1 905 997 3353; NATCO is a pharmaceutical …See details»
Natco Pharma Ltd - Regulatory Affairs and Compliance | The Org
The Regulatory Affairs and Compliance team at Natco Pharma Ltd is responsible for ensuring that the company's products meet all regulatory requirements and standards both domestically and …See details»
NATCO PHARMA LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NATCO PHARMA LIMITED of Mumbai, Maharashtra. Get the latest business insights from Dun & …See details»
Natco Pharma (Canada) Inc. announces the launch of (Pr)NAT
Sep 1, 2021 Natco Pharma (Canada) Inc. is the Canadian subsidiary of Natco Pharma Limited, a vertically integrated pharmaceutical company focused on research, development and …See details»
NATCO PHARMA (CANADA) INC | Drug and Health Products Portal
NATCO-CITALOPRAM: 02409003: Citalopram (Bromhydrate de citalopram) 10 MG NATCO-ESCITALOPRAM: 02554933: Escitalopram (Oxalate d'escitalopram) 20 MG NATCO …See details»
The Massive Failures of India’s Drug Regulatory System
Mar 12, 2025 The disclosures reinforced suspicions of regulatory collusion between government and the pharma industry. It emerged that 35 pharmaceutical companies had used electoral …See details»
NATCO PHARMA FULL ANALYSIS 2025 - by Ragav
Dec 22, 2024 Revlimid: Natco Pharma’s revenues for FY24 saw a significant boost from the sales of generic Revlimid (lenalidomide), which the company markets globally.This product …See details»
Blockbusters - Natco Pharma
Blockbusters - Natco Pharma. ... Natco through its marketing partner, Mylan NV launched the first generic version of Glatiramer Acetate, 40 mg in the USA in October, 2017. The drug has brand …See details»
Natco Pharma Ltd 7101 - Research and Analysis Report - ICICIdirect
Jun 1, 2022 Key Triggers for future price performance. US: Momentum likely amid contribution from gRevlimid, key being market formation post new competition. Focus on Para IV and FTF …See details»
Natco Pharma seeks USFDA nod for generic Erdafitinib Tablets
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (“FDF”) …See details»
Natco Pharma: Key Growth Drivers and Future Prospects
Dec 10, 2024 Natco Pharma trading at a P/E of 13.7, appears undervalued relative to its peers, particularly given its unique positioning in complex generics, high EBITDA margin, and robust …See details»